Clinical Study of an Investigational Obesity Drug and Its Heart Safety
AMR Newton is conducting a study to test an investigational drug on cardiovascular safety for people who are overweight or obese.
Qualified participants must:
- be ages 18 and older
- have a BMI of 27 or greater
- have cardiovascular disease, chronic kidney disease, or at least two risk factors for cardiovascular disease such as hypertension, dyslipidemia, Type 2 Diabetes, or Non-alcoholic steatohepatitis (NASH)
- meet other study criteria
Qualified participants will receive at no cost:
- all study-related care
- the investigational medication or placebo
Compensation for time and travel may be provided.
Learn more by calling AMR Newton at 316-283-0828 today!